NLTX   $0.8993  3.23% Market Closed

Neoleukin Therapeutics Inc
Total Cash 78.51M
totalCashPerShare 33.415
EBITDA -31.50M
Total Debt 10.69M
quickRatio 15.063
currentRatio 15.329
Total Revenue
debtToEquity 14.213
Revenue/Share
ROA -0.18705
ROE -0.37881002
grossProfits
freeCashflow -19.73M
operatingCashflow -32.28M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue -35.02M
forwardPE
floatShares 1.36M
sharesOutstanding 2.35M
sharesShort 6.60K
sharesShortPriorMonth 8.60K
dateShortInterest
sharesPercentSharesOut 0.00%
heldPercentInsiders
heldPercentInstitutions
Short Ratio help_outline 1.70%
shortPercentOfFloat 0.00%
impliedSharesOutstanding
bookValue 34.177
Price To Book help_outline 0.10
earningsQuarterlyGrowth
netIncomeToCommon -34.26M
trailingEps -12.28%
forwardEps -0.17%
enterpriseToEbitda 1.11
lastDividendValue
lastDividendDate
currentQuarterEstimate 2Q 2023
institutionsCount
lastUpdated Feb. 20, 2024, 3:16 p.m.